Carlos Cordon‐Cardo

97.5k citations
564 papers · 68.1k indexed · 26 hit papers · h-index 129
Topics
Cancer-related Molecular Pathways (100 papers)Bladder and Urothelial Cancer Treatments (89 papers)Epigenetics and DNA Methylation (56 papers)

In The Last Decade

Carlos Cordon‐Cardo

562 papers receiving 66.7k citations

Hit Papers

A microRNA polycistron as a potential human oncogene19892026200120132005200320072005198950010001.5k2.0k2.5k

Peers

Carlos Cordon‐Cardo
Comparison fields: 5 of 184
  • Molecular Biology 41.4k
  • Oncology 22.8k
  • Cancer Research 12.8k
  • Pulmonary and Respiratory Medicine 11.0k
  • Surgery 7.7k
Replace Mien‐Chie Hung with:
Mien‐Chie Hung United States
Daniel A. Haber United States
John D. Minna United States
Victor E. Velculescu United States
Adi F. Gazdar United States
Kornélia Polyák United States
Curtis C. Harris United States
Tyler Jacks United States
Raghu Kalluri United States
Scott W. Lowe United States
Carlos Cordon‐Cardo relative to Mien‐Chie Hung United States Mien‐Chie Hung's profile →
Citations per field
00.5×2.8×
Mien‐Chie Hung · 1×
Citations per year

Countries citing papers authored by Carlos Cordon‐Cardo

Since Specialization
Citations

This map shows the geographic impact of Carlos Cordon‐Cardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Cordon‐Cardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Cordon‐Cardo more than expected).

Fields of papers citing papers by Carlos Cordon‐Cardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Cordon‐Cardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Cordon‐Cardo. The network helps show where Carlos Cordon‐Cardo may publish in the future.

Co-authorship network of co-authors of Carlos Cordon‐Cardo

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Cordon‐Cardo. A scholar is included among the top collaborators of Carlos Cordon‐Cardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Cordon‐Cardo. Carlos Cordon‐Cardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 11
3 14
4 29
5 1
6 64
7 26
8 22
9 68
10 86
11 43
12 127
13 61
14 151
15 29
16 208
17 39
18
Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosisbreakdown →
1232
19 345
20 262

About Carlos Cordon‐Cardo

Carlos Cordon‐Cardo is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 564 papers that have together received 68.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (100 papers), Bladder and Urothelial Cancer Treatments (89 papers) and Epigenetics and DNA Methylation (56 papers). The work is most often cited by research in Cancer Research (12.8k citations), Oncology (22.8k citations) and Molecular Biology (41.4k citations). Carlos Cordon‐Cardo has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Pier Paolo Pandolfi, Scott W. Lowe, Eva Hernando, Marija Drobnjak, Zvi Fuks, Howard I. Scher, Antonio Di Cristofano, M R Melamed, Adriana Haimovitz‐Friedman and Gregory J. Hannon. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026